A global analysis of 125 turmeric supplements across five major markets revealed widespread inconsistencies in labeling, dosage, and regulatory compliance. Over a third lacked curcuminoid content disclosure, and nearly one-third exceeded safe intake levels, exposing consumers to unverified and potentially risky formulations.